Pages that link to "Q46068590"

The following pages link to Ro 16-6028: a novel anxiolytic acting as a partial agonist at the benzodiazepine receptor (Q46068590):

Displaying 42 items.

• Effects of a benzodiazepine, bretazenil (Ro 16-6028), on rhythmic metrazol EEG activity: comparison with standard anticonvulsants (Q28256473) (← links)
• Chronic bretazenil produces tolerance to chlordiazepoxide, midazolam, and abecarnil (Q28297031) (← links)
• Discriminative stimulus effects of alpidem, a new imidazopyridine anxiolytic (Q34319098) (← links)
• Benzodiazepine (omega) receptor partial agonists and the acquisition of conditioned fear in mice (Q34369227) (← links)
• Self-administration of bretazenil under progressive-ratio schedules: Behavioral economic analysis of the role intrinsic efficacy plays in the reinforcing effects of benzodiazepines (Q34510925) (← links)
• SL651498, a GABAA receptor agonist with subtype-selective efficacy, as a potential treatment for generalized anxiety disorder and muscle spasms. (Q35069575) (← links)
• The Mouse Defense Test Battery: pharmacological and behavioral assays for anxiety and panic (Q35071487) (← links)
• Convulsions induced by centrally administered NMDA in mice: effects of NMDA antagonists, benzodiazepines, minor tranquilizers and anticonvulsants (Q35756859) (← links)
• Electroencephalogram effect measures and relationships between pharmacokinetics and pharmacodynamics of centrally acting drugs (Q35759132) (← links)
• Animal models of anxiety and the development of novel anxiolytic drugs (Q36511808) (← links)
• Psychopharmacology of anxiety (Q36552298) (← links)
• The effect of intravenous flumazenil on interictal electroencephalographic epileptic activity: results of a placebo-controlled study (Q36946271) (← links)
• Pharmacology of the benzodiazepine receptor (Q38362813) (← links)
• Diazepam and gepirone selectively attenuate either 20-32 or 32-64 kHz ultrasonic vocalizations during aggressive encounters (Q38571831) (← links)
• Benzodiazepines in perspective (II): The GABAA-Benzodiazepine Receptor Ligands (Q40776362) (← links)
• GABA(A)-receptor subtypes: clinical efficacy and selectivity of benzodiazepine site ligands. (Q41647720) (← links)
• Differences in intrinsic efficacy of benzodiazepines are reflected in their concentration-EEG effect relationship (Q41827086) (← links)
• The pharmacological properties of Y-23684, a benzodiazepine receptor partial agonist (Q42132920) (← links)
• Sarmazenil-precipitated withdrawal: a reliable method for assessing dependence liability of benzodiazepine receptor ligands (Q42542479) (← links)
• Abecarnil, a beta-carboline derivative, does not exhibit anticonvulsant tolerance or withdrawal effects in mice (Q42552262) (← links)
• Behavioral effects of flunitrazepam: reinforcing and discriminative stimulus effects in rhesus monkeys and prevention of withdrawal signs in pentobarbital-dependent rats (Q43571804) (← links)
• Mechanism-based pharmacodynamic modeling of the interaction of midazolam, bretazenil, and zolpidem with ethanol (Q44227572) (← links)
• Pharmacological evaluation of (S)-8-[123I]iodobretazenil: a radioligand for in vivo studies of central benzodiazepine receptors (Q44353088) (← links)
• Pharmacological studies on synthetic flavonoids: comparison with diazepam (Q48148737) (← links)
• Effects of immobilization stress and of a benzodiazepine derivative on rat central dopamine system (Q48494277) (← links)
• Binding Profiles and Physical Dependence Liabilities of Selected Benzodiazepine Receptor Ligands (Q48496071) (← links)
• Benzodiazepine-GABAA receptor complex ligands in two models of anxiety (Q48770244) (← links)
• Further evidence for differences between non-selective and BZ-1 (omega 1) selective, benzodiazepine receptor ligands in murine models of "state" and "trait" anxiety (Q48783302) (← links)
• Precipitated withdrawal in squirrel monkeys after repeated daily oral administration of alprazolam, diazepam, flunitrazepam or oxazepam (Q48823071) (← links)
• Pharmacological characterization of benzodiazepine receptor ligands with intrinsic efficacies ranging from high to zero (Q48880079) (← links)
• Behavioural effects of the benzodiazepine receptor partial agonist RO 16-6028 in mice (Q48933156) (← links)
• Rat pup ultrasonic vocalization: effects of benzodiazepine receptor ligands (Q51093668) (← links)
• Safety signal withdrawal: a behavioural paradigm sensitive to both "anxiolytic" and "anxiogenic" drugs under identical experimental conditions (Q51164182) (← links)
• Study of the modulatory activity of BZ (omega) receptor ligands on defensive behaviors in mice: evaluation of the importance of intrinsic efficacy and receptor subtype selectivity (Q51455021) (← links)
• Differences in anxiolytic-like profile of two novel nonbenzodiazepine BZ (omega) receptor agonists on defensive behaviors of mice (Q51464353) (← links)
• The use of the rat elevated plus-maze to discriminate between non-selective and BZ-1 (omega 1) selective, benzodiazepine receptor ligands (Q51573979) (← links)
• Comparison of several benzodiazepine receptor ligands in two models of anxiolytic activity in the mouse: an analysis based on fractional receptor occupancies. (Q52218225) (← links)
• Conditioned place preference induced by Ro 16-6028, a benzodiazepine receptor partial agonist (Q52232073) (← links)
• An update on GABAA receptors (Q56601749) (← links)
• Vascular toxicity in dogs associated with overdoses of a novel benzodiazepine receptor partial agonist (Q68238665) (← links)
• Determination of the partial benzodiazepine receptor agonist Ro 16-6028 in plasma by capillary gas chromatography with nitrogen-selective detection after conversion into the ethyl ester derivative (Q69376366) (← links)
• Poster communications (Q83084116) (← links)